Welcome to our dedicated page for iPath Series B Carbon Exchange-Traded Notes news (Ticker: GRN), a resource for investors and traders seeking the latest updates and insights on iPath Series B Carbon Exchange-Traded Notes stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect iPath Series B Carbon Exchange-Traded Notes's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of iPath Series B Carbon Exchange-Traded Notes's position in the market.
Greenlane Renewables reported a record revenue of $8.8 million in Q4 2020, up 167% from Q4 2019. Full-year revenue also hit $22.5 million, a 147% increase. The gross margin for Q4 was 27%, while the adjusted EBITDA was $0.2 million. The company ended the year with a significant sales order backlog of $45.7 million, reflecting a 180% year-over-year rise. Despite a net loss of $1.2 million in Q4, the outlook remains positive, supported by increasing market activity and expansion into new projects.
FAQ
What is the current stock price of iPath Series B Carbon Exchange-Traded Notes (GRN)?
